Live Breaking News & Updates on Sirolimus Angioinfusion Balloon

Stay updated with breaking news from Sirolimus angioinfusion balloon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis

Virtue® Sirolimus AngioInfusion Balloon is the only non-coated angioplasty system providing protected delivery of extended release sirolimus under clinical investigation worldwideVirtue ISR-US. ....

United States , Kelsey Kirk Ellis , Sirolimus Angioinfusion , Darrenr Sherman , Bob Yedid , Drug Administration , Terumo Medical Corporation , Christ Hospital Heart Vascular Institute , Ohio State University , Exchange Commission On , Orchestra Biomed Holdings Inc , Terumo Corporation , National Cardiovascular Data Registry , Christ Hospital Research Institute , Sirolimus Angioinfusion Balloon , Biomed Holdings , Chief Operating Officer , Old Balloon Angioplasty , Orchestra Biomed , Christ Hospital Heart , Vascular Institute , Medical Director , Clinical Medicine , Principal Investigator , Institutional Review Board , Coronary In Stent Restenosis ,